Life sciences
Scientists at Imperial College London say their research into a test for long COVID may also find potential treatments for the condition. Professor Danny Altmann, from Imperial College London’s Department of Immunology and Inflammation, is working on understanding why some people have persistent symptoms of COVID-19, while others recover fully from the infection. His team is [...]
Scientists have discovered a new method to produce the complex antibiotics urgently required to combat antimicrobial resistance, treat neglected diseases and tackle future pandemics. Researchers from the University of Manchester have discovered a new way of manipulating key assembly line enzymes in bacteria which they say could pave the way for a new generation of [...]
Researchers have developed a new technology, based on nanoparticles, to kill dangerous bacteria that hide inside human cells. Burkholderia is a genus of bacterium that causes a deadly disease called melioidosis. This disease kills tens of thousands of people each year, particularly in southeast Asia. Antibiotics administered orally or intravenously often don’t work very well [...]
Imperial College London’s COVID-19 Response Team has developed a new tool to assess the threat of new variants, including the new Omicron variant, in real-time. The MV-EpiEstim tool (MV: multivariant) can be used to estimate the transmission advantage of the new Omicron COVID-19 variant. The team say that the method can be a useful tool for [...]
Scientists have made a breakthrough discovery that could advance the treatment of Alzheimer’s Disease. Researchers from the University of Glasgow and the biotechnology company Sosei-Heptares Ltd, have designed a new molecule that selectively targets a specific receptor protein in the brain. Professor Andrew Tobin, professor of molecular pharmacology at the University of Glasgow, said the [...]
Life sciences investment group NetScientific plc has invested a further $1m into EpiBone Inc, a regenerative medicine company that focuses on bone and cartilage reconstruction based in the US. The investment comprises of $734k from NetScientific’s balance sheet and $266k in advised funds from the group’s corporate finance and venture capital subsidiary EMV Capital Ltd. [...]
Jaymin Amin, CEO of ProFactor Pharma (PFP), discusses the company's life-changing, and life-saving, work. PFP says it has developed a low-cost production process for creating human factor VIII (rhFVIII), a complex protein which induces blood clotting and is used to treat haemophilia A. There is a severe worldwide shortage of rhFVIII and PFP has developed a patent [...]
Research has identified a way of using nanoclusters to bolster waning antibiotics. Tiny particles of gold could be a new weapon in the fight against bacterial antibiotic resistance, research by an international team of scientists has revealed. Scientists have been investigating the use of gold nanoclusters, each made up of 25 atoms of gold, to [...]
A novel clot-busting drug formulated and tested by University of Manchester scientists is able to effectively restore blood flow in the brains of mice, opening the door for a safer and more effective stroke treatment. The compound, an enzyme called caADAMTS13, could dissolve clots in patients that are resistant to current treatment, according to the [...]
Teesside University, based in North East England, has launched a programme to show students what a career in the life sciences could look like. The first cohort of the Life Sciences Manufacturing Academy saw students from Darlington College spending a week at Teesside University’s National Horizons Centre, hearing from their biotech experts, and colleagues from [...]
